...
首页> 外文期刊>Journal of the advanced practitioner in oncology >Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
【24h】

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma

机译:卡波替尼治疗转移性甲状腺髓样癌

获取原文
获取原文并翻译 | 示例
           

摘要

Thyroid cancer is increasing at a faster rate than any other cancer type in the United States, with a total of 60,220 new cases expected in 2013 (American Cancer Society, 2013). It is the fifth most commonly diagnosed cancer in women, but it is much less prevalent in men. Thyroid cancer is generally associated with a high cure rate, yet medullary thyroid carcinoma (MTC) in particular is more aggressive and tends to metastasize.
机译:甲状腺癌的增长速度超过了美国任何其他癌症类型,2013年预计将有60,220例新病例(美国癌症协会,2013年)。它是女性中第五种最常被诊断出的癌症,但在男性中却不那么普遍。甲状腺癌通常具有较高的治愈率,但是甲状腺髓样癌(MTC)更具有侵略性,并且易于转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号